SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-001580
Filing Date
2021-07-15
Accepted
2021-07-15 17:21:59
Documents
98
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 982759
2 EX-4.1 lxrp_ex41.htm EX-4.1 87214
3 EX-10.1 lxrp_ex101.htm EX-10.1 82246
4 EX-31.1 lxrp_ex311.htm EX-31.1 9895
5 EX-31.2 lxrp_ex312.htm EX-31.2 9912
6 EX-32.1 lxrp_ex321.htm EX-32.1 5053
7 EX-32.2 lxrp_ex322.htm EX-32.2 5236
13 lxrp_10qimg1.jpg GRAPHIC 1582
  Complete submission text file 0001640334-21-001580.txt   5670608

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20210531.xsd EX-101.SCH 65069
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20210531_lab.xml EX-101.LAB 332462
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20210531_cal.xml EX-101.CAL 60303
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20210531_pre.xml EX-101.PRE 275892
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20210531_def.xml EX-101.DEF 115958
14 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 1013219
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 211093462
SIC: 2834 Pharmaceutical Preparations